Clinic
Maryland Oncology Hematology, P.A.
Maryland Oncology Hematology, P.A. was paid $3.09M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 16% of everything it billed.
33Billing provider infoMARYLAND ONCOLOGY HEMATOLOGY, P.A.
LAUREL, MD 20707
LAUREL, MD 20707
33aNPI1821271032assigned 12/11/2007
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$3.09M
24GClaims98,744
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Maryland
Rank by total paid#4 of 37
Median peer was paid$471K
This provider vs. median6.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIS, ROBERT controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,601 | $482K | |
| 2019 | 14,139 | $449K | |
| 2020 | 10,928 | $266K | |
| 2021 | 10,325 | $236K | |
| 2022 | 21,305 | $942K | |
| 2023 | 15,963 | $379K | |
| 2024incomplete | 12,483 | $338K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 14,078 | 11,060 | $480K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 13% | 7,539 | 4,324 | $397K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 13,628 | 11,564 | $366K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 12% | 3,345 | 2,526 | $358K |
| J0897 | Injection, denosumab, 1 mg | 7.6% | 1,413 | 1,283 | $234K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 4.2% | 2,248 | 1,797 | $129K |
| 96367 | 4.2% | 5,014 | 2,825 | $128K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.5% | 8,993 | 6,435 | $108K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3.1% | 2,624 | 1,489 | $95K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.9% | 4,771 | 2,790 | $90K |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 2.5% | 176 | 82 | $76K |
| 96401 | 2.1% | 1,043 | 539 | $66K |
48 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 2.0% | 4,482 | $61K |
| 96417 | 1.8% | 1,800 | $54K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.7% | 1,257 | $54K |
| J2505 | Injection, pegfilgrastim, 6 mg | 1.6% | 606 | $48K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.5% | 1,012 | $46K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1.4% | 4,532 | $42K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 723 | $33K |
| J3490 | Unclassified drugs | <1% | 985 | $29K |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 329 | $28K |
| 96415 | <1% | 1,227 | $26K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,814 | $19K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 2,813 | $13K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 636 | $12K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | <1% | 90 | $11K |
| J0185 | Injection, aprepitant, 1 mg | <1% | 636 | $10K |
| 99205 | Prolong outpt/office vis | <1% | 112 | $9K |
| 96377 | <1% | 270 | $8K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 638 | $8K |
| J9045 | Injection, carboplatin, 50 mg | <1% | 118 | $6K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 772 | $5K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 59 | $5K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 83 | $5K |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 65 | $5K |
| 96402 | <1% | 332 | $4K | |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 40 | $4K |
| 96368 | <1% | 206 | $3K | |
| 96416 | <1% | 42 | $3K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,248 | $3K |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 250 | $2K |
| 99223 | Prolong inpt eval add15 m | <1% | 12 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 92 | $1K |
| 82746 | <1% | 452 | $764.40 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 25 | $648.81 |
| 82607 | <1% | 263 | $458.28 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 309 | $432.59 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 28 | $348.25 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 37 | $343.44 |
| 83615 | <1% | 55 | $325.60 | |
| 82728 | <1% | 579 | $132.07 | |
| 83550 | <1% | 595 | $94.24 | |
| 83540 | <1% | 595 | $51.80 | |
| 96523 | <1% | 19 | $20.49 | |
| 82378 | 0% | 41 | $0.00 | |
| 90674 | 0% | 12 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 12 | $0.00 |
| J1453 | Injection, fosaprepitant, 1 mg | 0% | 490 | $0.00 |
| J9035 | Injection, bevacizumab, 10 mg | 0% | 34 | $0.00 |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIS, ROBERT (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Carolina Outreach, LLC | Fayetteville, NC | $17.95M |
| University of South Alabama | Mobile, AL | $7.37M |
| Transportation Administration of Cleveland County INC. | Shelby, NC | $3.47M |
| Pennock Hospital | Ionia, MI | $2.57M |
| Alert Ambulance Service, INC | Lakewood, NJ | $1.14M |
| Dentistry for Children and Teens INC. | East Liverpool, OH | $855K |
| Muhlenberg County Schools | Powderly, KY | $694K |
| Davis Medical Clinic LTD | Vernon, AL | $642K |
| Sullivan County Auditor | Sullivan, IN | $415K |
| Dentistry for Children and Teens INC. | Beaver, PA | $52K |
| Vanguard Imaging INC | Coal Grove, OH | $12K |
| The Pathology Center | Bellefontaine, OH | $10K |
| Robert A. Davis Od PA | Pembroke Pines, FL | $51.72 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.